According to the World Health Organization (WHO), lenacapavir offers a highly effective, long-acting alternative to daily ...

Year's supply of injectable to cost Rs 3,549, compared to over Rs 17 lakh in US. Powerful alternative to daily oral PrEP, ...

In his first term, President Trump pledged to boost HIV spending, with the lofty goal of bringing the epidemic to heel by ...

By the end of 2024, Bangladesh had registered 12,422 cumulative HIV cases, of which 2,281 had died. Health experts estimate that around 16,863 people are currently living with HIV in the country.

Lots of scholarship assumes that partners in higher-quality relationships work together to reduce health-related risks. A new study tested this assumption.

A new survey launched by Global Black Gay Men Connect is seeking responses from Black gay men and Black trans community ...

Gilead's groundbreaking HIV prevention drug will soon be available at a fraction of its U.S. price in over 100 countries, ...

Lenacapavir, approved by the FDA in June, requires only two shots a year. US insurers don't cover it, but access will soon ...

A twice-yearly injection described as the most promising HIV prevention tool in decades is poised to reach millions more people, with new generic versions priced at about $40 per patient per year.

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...

The South Carolina Department of Public Health (DPH) is observing its sixth annual PrEP (pre-exposure prophylaxis) Awareness ...